Axonics® to Report First Quarter 2022 Financial Results on May 5
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
Day: April 14, 2022
Tivic Health to Report 2021 Fourth Quarter & Year-End Shareholder Update on Tuesday, April 19
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”) a commercial-phase health technology company that develops...
Intellipharmaceutics Announces First Quarter 2022 Results
TORONTO, ON / ACCESSWIRE / April 14, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...
NCODA and XIFIN Launch New Initiative to Expand Oncology Patient Care Options
“NCODA Informatics Initiative Powered by VisualStrata” Helps Attract Clinical Trials for Oncology Practices and Bridges the Gap with Pharmaceutical Organizations...
UpStream Moves to the Innovaccer Health Cloud to Accelerate Transformation of U.S. Healthcare
Innovative provider will use the Innovaccer Health Cloud’s unified patient record to support value-based, whole-person care delivery for older patients...
Marijuana Company of America, Inc. to Present at Sequire Cannabis & Psychedelics Conference
LOS ANGELES, CA / ACCESSWIRE / April 14, 2022 / Marijuana Company of America, Inc. (OTC:MCOA) ("the Company"), operates, invests,...
Saint Therese CEO Barb Rode to Be Inducted into McKnight’s Hall of Honor
Receives national honor on the eve of her retirement after 22 years with Saint ThereseSAINT LOUIS PARK, MN / ACCESSWIRE...
Xcelerate, Inc. (OTC Markets: XCRT) Retains SmallCapVoice.com Inc. to Provide Investor Relations Services
MAULDIN, SC / ACCESSWIRE / April 14, 2022 / Xcelerate, Inc. (OTC Markets:XCRT) today announced it has retained SmallCapVoice.com Inc.,...
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on...
Planet 13 Nevada Cultivation Expansion Fuels SuperStore In-House Product Growth
LAS VEGAS, NV / ACCESSWIRE / April 14, 2022 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),a...
Stereotaxis to Report First Quarter Financial Results on May 10, 2022
ST. LOUIS, April 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
Longeveron to Present at Longevity Leaders World Congress; Latinos and Alzheimer’s Symposium; International Frailty and Sarcopenia Research Conference
April events to highlight Longeveron’s commitment to developing cell therapeutics for chronic aging related diseases.MIAMI, April 14, 2022 (GLOBE NEWSWIRE)...
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
Q3 Net loss per share of $0.01 vs. a net loss of $0.18 per share from same period last yearInFoods®...
Agios Announces Publication of Phase 3 ACTIVATE Study in New England Journal of Medicine Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults with Pyruvate Kinase Deficiency
– In Adults with Pyruvate Kinase (PK) Deficiency Who Are Not Regularly Transfused, PYRUKYND® Significantly Increased Hemoglobin Level, Decreased Hemolysis...
Junshi Biosciences and Coherus Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
SHANGHAI, China and REDWOOD CITY, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX:...
Smart For Life to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st
MIAMI, April 14, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a...
Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual Meeting
Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients was well received at 2022 AACR Annual...
Coherus and Junshi Biosciences Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
REDWOOD CITY, Calif., and SHANGHAI, China, April 14, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) and Shanghai Junshi...
Sol-Gel Technologies Announces the Commercial Availability of TWYNEO®
TWYNEO is the first-ever tretinoin and benzoyl peroxide combination to treat facial acneSol-Gel’s U.S. commercialization partner, Galderma, launched TWYNEO® in...
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million
BEIJING, April 14, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...